Clinical Trial Update: Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating losartan, a renin-angiotensin system inhibitor, for hypertrophic cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Henning Bundgaard | Conditions: Hypertrophic Cardiomyopathy | Phase 2 | Status: COMPLETED